- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Polythiazide
Allopathy
Prescription Required
DCGI (Drugs Controller General of India)
Schedule H
Polythiazide is an antihypertensive agent belonging to Thiazide Diuretics.
Polythiazide is a thiazide diuretic used to treat hypertension and edema in congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy.
Polythiazide is readily absorbed from the GI tract. Approximately >80% of Plasma protein binding. The plasma half-life of polythiazide is approximately 26 hours. After oral administration, Polythiazide is excreted via urine as an unchanged drug and feces.
Polythiazide shows common side effects like Low blood pressure, Increased blood sugar levels, Nausea and Vomiting, Diarrhoea, Stomach cramps, Dizziness, Fatigue, etc.
Polythiazide is available in the form of Oral Tablets.
Polythiazide is available in India, China, the US, Canada, the UK, and Hong Kong.
Polythiazide belonging to the Thiazide Diuretics, acts as an antihypertensive agent.
As a diuretic, Polythiazide inhibits active chloride reabsorption at the early distal tubule via the thiazide-sensitive Na-Cl cotransporter (TSC), resulting in an increase in the excretion of sodium, chloride, and water. Thiazides like polythiazide also inhibit sodium ion transport across the renal tubular epithelium through binding to the thiazide-sensitive sodium-chloride transporter. This results in an increase in potassium excretion via the sodium-potassium exchange mechanism. The antihypertensive mechanism of polythiazide may be mediated through its action on carbonic anhydrases in the smooth muscle or through its action on the large-conductance calcium-activated potassium (KCa) channel, also found in the smooth muscle.
The onset of action of Polythiazide occurs within 2 hours.
The Duration of Action for Polythiazide in the body is approximately 24-48 hours.
Polythiazide is available in the form of Oral Tablets taken by mouth usually once a day.
Polythiazide is a thiazide diuretic used to treat hypertension and edema in congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy.
Polythiazide is an antihypertensive agent belonging to Thiazide Diuretics. Polythiazide inhibits active chloride reabsorption at the early distal tubule via the thiazide-sensitive Na-Cl cotransporter (TSC), resulting in an increase in the excretion of sodium, chloride, and water. Polythiazide is a thiazide diuretic used to treat fluid retention (edema) in people with congestive heart failure, cirrhosis of the liver, kidney disorders, or edema caused by taking steroids or estrogen.
Polythiazide is approved for use in the following clinical indications
- Edema
Polythiazide is indicated as adjunctive therapy in the edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. Polythiazide has also been found useful in edema due to various forms of renal dysfunction as Nephrotic syndrome; Acute glomerulonephritis; and Chronic renal failure.
- Hypertension
Polythiazide is indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension.
- Edema
In the treatment of edema, the usual dose is 1 to 4 mg daily.
- Hypertension
In the treatment of hypertension, the usual dose is 2 to 4 mg daily.
Polythiazide is available in various strengths as 1mg, 2mg, and 4mg.
Polythiazide is available in the form of Oral Tablets.
Avoid consumption of a high-salt or high-sodium diet while taking Polythiazide.
Polythiazide is contraindicated in patients with
- Anuria
- Hypersensitivity to this or other sulfonamide-derived drugs.
- Renal decompensation
- Pregnancy
- Renal disease
Thiazides should be used with caution in severe renal disease. In patients with renal disease, thiazides may precipitate azotemia. Cumulative effects of the drug may develop in patients with impaired renal function.
- Liver disease
Thiazides should be used with caution in patients with impaired hepatic function or progressive liver disease, since minor alterations of fluid and electrolyte balance may precipitate hepatic coma.
- Allergy or bronchial asthma
Sensitivity reactions may occur in patients with a history of allergy or bronchial asthma. The possibility of exacerbation or activation of systemic lupus erythematosus has been reported.
- Fluid or electrolyte imbalance
Periodic determination of serum electrolytes to detect possible electrolyte imbalance should be performed at appropriate intervals. All patients receiving thiazide therapy should be observed for clinical signs of fluid or electrolyte imbalance; namely, hyponatremia, hypochloremic alkalosis, and hypokalemia. Serum and urine electrolyte determinations are particularly important when the patient is vomiting excessively or receiving parenteral fluids. Medication such as digitalis may also influence serum electrolytes. Warning signs, irrespective of cause, are dryness of mouth, thirst, weakness, lethargy, drowsiness, restlessness, muscle pains or cramps, muscular fatigue, hypotension, oliguria, tachycardia, and gastrointestinal disturbances such as nausea and vomiting.
- Hypokalemia
Hypokalemia may develop with thiazides as with any other potent diuretic, especially with brisk diuresis, when severe cirrhosis is present, or during concomitant use of corticosteroids or ACTH. Interference with adequate oral electrolyte intake will also contribute to hypokalemia. Digitalis therapy may exaggerate the metabolic effects of hypokalemia, especially with reference to myocardial activity.
- Hyponatremia
Any chloride deficit is generally mild and usually does not require specific treatment except under extraordinary circumstances (as in liver disease or renal disease). Dilutional hyponatremia may occur in edematous patients in hot weather; appropriate therapy is water restriction, rather than administration of salt except in rare instances when the hyponatremia is life-threatening. In actual salt depletion, appropriate replacement is the therapy of choice.
- Hyperuricemia
Hyperuricemia may occur or frank gout may be precipitated in certain patients receiving thiazide therapy.
- In diabetic patients
Insulin requirements in diabetic patients may be increased, decreased, or unchanged. Latent diabetes mellitus may become manifest during thiazide administration.
Alcohol Warning
Consumption of alcohol is not recommended while taking Polythiazide due to the increased risk of low blood pressure.
Breast Feeding Warning
Thiazides appear in breast milk. If the use of the drug is deemed essential, the patient should stop nursing.
Pregnancy Warning
The routine use of diuretics in an otherwise healthy woman is inappropriate and exposes the mother and fetus to unnecessary hazards. Diuretics do not prevent the development of toxemia in pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed toxemia.
Food Warning
Avoid consumption of a high-salt or high-sodium diet while taking Polythiazide.
- Common Adverse effects
Weakness, Orthostatic hypotension, Pancreatitis, Jaundice, Nausea, vomiting, Sialadenitis, Abdominal cramping, Urticaria/erythema multiforme/exfoliative dermatitis, Purpura, Muscle spasm, Vertigo/dizziness, Paresthesias, Diarrhea/Constipation, Gastric irritation, Aplastic anemia, Agranulocytosis, Fever, Headache, Restlessness.
- Rare Adverse effects
Hypokalemia, hyponatremia, hypercalcemia, and/or hypomagnesemia, Necrotizing angiitis, Pneumonitis, and pulmonary edema, azotemia, acute transient myopia, and acute angle-closure glaucoma, Leukopenia, Hemolytic anemia, Photosensitivity, Transient blurred vision, Xanthopsia, Impotence, Hyperuricemia, Thrombocytopenia, Hyperglycemia.
- ACTH or Corticosteroids: Hypokalemia may develop with concomitant use of ACTH or Corticosteroids.
- Beta-blocker: Hyperglycemia may develop with concomitant treatment in Type 2 diabetes mellitus.
- Barbiturates or Narcotics: Orthostatic hypotension may be aggravated with Barbiturates or Narcotics.
- Cyclosporine: Avoid concurrent use of cyclosporine and thiazides may increase the risk of gout or renal toxicity.
- Digoxin: Metabolic effects of hypokalemia may be increased with concomitant digitalis therapy.
- Lithium: Lithium toxicity can occur with concomitant therapy which reduces renal excretion of lithium.
- NSAIDs: NSAIDs can decrease the efficacy of thiazides reducing the diuretic and antihypertensive effects.
The common side of Polythiazide includes the following
- Common
Low blood pressure, Increased blood sugar levels, Nausea and Vomiting, Diarrhoea, Stomach cramps, Dizziness, and Fatigue.
- Rare
Hemolytic anemia, Thrombocytopenia, Necrotizing angiitis, Pneumonitis, and pulmonary edema, Photosensitivity, Fever, Weight gain, Redness of the eye, sexual problems, Pancreatitis, Jaundice, Nausea/vomiting, Sialadenitis, Aplastic anemia, Agranulocytosis, Leukopenia.
- Pregnancy
Pregnancy Category D.
Thiazides cross the placental barrier and appear in cord blood. The use of thiazides in pregnant women requires that the anticipated benefit be weighed against possible hazards to the fetus. These hazards include fetal or neonatal jaundice, thrombocytopenia, and possibly other adverse reactions which have occurred in the adult.
- Nursing Mothers
Thiazides appear in breast milk. If the use of the drug is deemed essential, the patient should stop nursing.
- Pediatric Use
Safety and effectiveness in pediatric patients have not been established.
- Geriatric Use
Data is not available.
No information was available.
Pharmacodynamic
As a thiazide diuretic, Polythiazide inhibits the sodium-chloride symporter which decreases solute reabsorption leading to a retention of water in the urine, as water normally follows solutes. More frequent urination is due to the increased loss of water that has not been retained from the body as a result of a concomitant relationship with sodium loss from the convoluted tubule. The short-term anti-hypertensive action is based on the fact that thiazides decrease preload, decreasing blood pressure.
Pharmacokinetics
- Absorption
Readily absorbed from the GI tract.
- Distribution
Plasma protein binding: >80%.
- Metabolism and Excretion
Via urine (as unchanged drug) and feces. Elimination half-life: Approx 26 hr.
- Scriabine A, Korol B, Kondratas B, Yu M, P'an SY, Schneider JA. Pharmacological studies with polythiazide, a new diuretic and antihypertensive agent. Proceedings of the Society for Experimental Biology and Medicine. 1961 Aug;107(4):864-72.
- Scriabine A, Schreiber EC, Yu M, Wiseman EH. Renal clearance of polythiazide. Proceedings of the Society for Experimental Biology and Medicine. 1962 Aug;110(4):872-5.
- Spiekerman RE. Polythiazide and Chlorothiazide-Reply. JAMA. 1963 Oct 5;186(1):81-2.
- https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=abd6ecf0-dc8e-41de-89f2-1e36ed9d6535&type=display
- https://go.drugbank.com/drugs/DB01324
- https://www.syrianclinic.com/med/en/ProfDrugs/Polythiazidepd.html#drug-interactions
- https://www.rxlist.com/renese-drug.htm